This research report presents an in-depth analysis of the global
cognition and memory-enhancing drugs market by application, product
categories, and regional markets. The report includes key cognition
drugs that are incorporated in several therapeutic treatment methods. It
discusses the role of supply chain members from manufacturers to
researchers.

The report has an in-depth analysis of key companies operating in the
global cognition and memory-enhancing drugs market. In-depth patent
analysis in the report will focus on providing extensive technological
trends across years and regions such as the U.S., Europe, and China.

The cognition and memory-enhancing drugs market is segmented mainly into
eight components: Aricept, Exelon, Reminyl, Namenda, Adderall, Ritalin,
Dexedrin, and other cognition drugs. This market is further segmented on
the basis of applications, which helps in understanding the potency of
these memory enhancers in several therapeutic treatments.

The market study is detailed for products based on applications as well
as its further implication on the research and development area. These
two segmentations are also discussed in detail for the given period. The
market is segmented by region into the North America, Europe,
Asia-Pacific, and ROW.

Report Scope

An overview of the global market for cognition and memory enhancement
drugs

Analyses of global market trends, with data from 2016 to 2017, and
projections of compound annual growth rates (CAGRs) through 2022

An overview of the ethics and side effects of cognition and memory
enhancement drugs

Market analyses by application, product, and region

Assessment of patent litigation claims

Insight into the competitive landscape, including mergers and
acquisitions and new product launches